keyword
MENU ▼
Read by QxMD icon Read
search

Mucosal leishmaniasis

keyword
https://www.readbyqxmd.com/read/29095818/dynamics-of-american-tegumentary-leishmaniasis-in-a-highly-endemic-region-for-leishmania-viannia-braziliensis-infection-in-northeast-brazil
#1
Juliana Silva, Adriano Queiroz, Izabella Moura, Rosana S Sousa, Luiz Henrique Guimarães, Paulo Roberto Lima Machado, Marcus Lessa, Ednaldo Lago, Mary E Wilson, Albert Schriefer
BACKGROUND: American Tegumentary Leishmaniasis (ATL) caused by Leishmania braziliensis is endemic in Corte de Pedra, Northeast Brazil. Most L. braziliensis infections manifest as localized cutaneous leishmaniasis (CL). Disseminated manifestations include mucosal leishmaniasis (ML), present at a low constant level for several decades, and newly emerging disseminated leishmaniasis (DL). Surprisingly, DL has recently surpassed ML in its spatial distribution. This led us to hypothesize that distinct forms of ATL might spread in different patterns through affected regions...
November 2017: PLoS Neglected Tropical Diseases
https://www.readbyqxmd.com/read/29042262/molecular-epidemiology-and-in-vitro-evidence-suggest-that-leishmania-braziliensis-strain-helps-determine-antimony-response-among-american-tegumenary-leishmaniasis-patients
#2
Silvana C Silva, Luiz Henrique Guimarães, Juliana A Silva, Viviane Magalhães, Lilian Medina, Adriano Queiroz, Paulo Roberto L Machado, Albert Schriefer
Antimony is the first line drug for treating American tegumentary leishmaniasis (ATL) in Brazil. In this country, Leishmania braziliensis causes at least three distinct forms of disease: localized cutaneous (CL), mucosal (ML) and disseminated leishmaniasis (DL). All forms can be found in Corte de Pedra, Northeast Brazil. ML and DL respond poorly to antimony, in contrast to CL. The L. braziliensis population causing ATL in Corte de Pedra is genetically very diverse, with strains of the parasite associating with the clinical form of leishmaniasis...
October 16, 2017: Acta Tropica
https://www.readbyqxmd.com/read/29031288/case-report-old-world-mucosal-leishmaniasis-report-of-five-imported-cases-to-the-hospital-for-tropical-diseases-london-united-kingdom
#3
Trupti A Patel, Glenis K Scadding, David E Phillips, Diana N Lockwood
Old World species of Leishmania typically cause visceral and cutaneous leishmaniasis. Mucosal involvement is typically seen with infection by Leishmania species found in South America, usually after the healing of cutaneous leishmaniasis. We present five imported cases of mucosal leishmaniasis caused by Old World Mediterranean Leishmania infantum exclusively affecting the nasal mucosa or vocal cord. In only one case was there a recollection of a preceding cutaneous lesion compatible with cutaneous Leishmaniasis...
October 2017: American Journal of Tropical Medicine and Hygiene
https://www.readbyqxmd.com/read/29016694/efficacy-of-azole-therapy-for-tegumentary-leishmaniasis-a-systematic-review-and-meta-analysis
#4
REVIEW
Endi Lanza Galvão, Ana Rabello, Gláucia Fernandes Cota
BACKGROUND: Several controlled and uncontrolled studies addressing azole antifungal drugs for cutaneous and mucosal leishmaniasis have been published with inconclusive results. We conducted a systematic literature review of studies evaluating the efficacy and toxicity associated with azole therapy for tegumentary leishmaniasis. METHODOLOGY: PRISMA guidelines for systematic reviews and the Cochrane manual were followed, and the review methodology was registered (PROSPERO; CRD42016048668)...
2017: PloS One
https://www.readbyqxmd.com/read/28981507/reappraisal-of-leishmanin-skin-test-lst-in-the-management-of-american-cutaneous-leishmaniasis-a-retrospective-analysis-from-a-reference-center-in-argentina
#5
Alejandro Javier Krolewiecki, Maria Cristina Almazan, Marcelo Quipildor, Marisa Juarez, Jose Fernando Gil, Marco Espinosa, Maria Canabire, Silvana Pamela Cajal
Leishmania (Viannia) braziliensis is the species most frequently implicated with cutaneous and mucosal leishmaniasis in the Americas; its diagnosis is based on the identification of amastigotes in lesions, which is limited by low parasite burden. Leishmanin Skin Test (LST) is a support tool for diagnosis, based on delayed type hypersensitivity responses to Leishmania antigens injected intradermally, used in endemic areas as a complement to diagnosis. A retrospective analysis of individuals evaluated for their first episode of tegumentary leishmaniasis at a reference center in Argentina during the period 2006-2015 was performed, with the goal of assessing its usefulness as a support tool in the diagnosis of leishmaniasis...
October 2017: PLoS Neglected Tropical Diseases
https://www.readbyqxmd.com/read/28968786/influence-of-leishmania-rna-virus-1-on-proinflammatory-biomarker-expression-in-a-human-macrophage-model-of-american-tegumentary-leishmaniasis
#6
Ruwandi Kariyawasam, Jugvinder Grewal, Rachel Lau, Andrew Purssell, Braulio M Valencia, Alejandro Llanos-Cuentas, Andrea K Boggild
Backgound: Species of the Leishmania Viannia (L. V.) subgenus harbor the double-stranded Leishmania RNA virus 1 (LRV-1), previously identified in isolates from Brazil and Peru. Higher levels of LRV-1 in metastasizing strains of L. V. guyanensis have been documented in both human and murine models, and correlated to disease severity. Methods: Expression of proinflammatory biomarkers, including interleukin (IL) 1β, tumor necrosis factor alpha (TNF-α), CXCL10, CCL5, IL-6, and superoxide dismutase, in human macrophages infected with 3 ATCC and 5 clinical isolates of L...
October 17, 2017: Journal of Infectious Diseases
https://www.readbyqxmd.com/read/28934199/mucosal-leishmaniasis-mimicking-t-cell-lymphoma-in-a-patient-receiving-monoclonal-antibody-against-tnf%C3%AE
#7
Antonio Carlos Nicodemo, Daniel Fernandes Duailibi, Diego Feriani, Maria Irma Seixas Duarte, Valdir Sabbaga Amato
No abstract text is available yet for this article.
September 2017: PLoS Neglected Tropical Diseases
https://www.readbyqxmd.com/read/28926630/efficacy-of-pentavalent-antimoniate-intralesional-infiltration-therapy-for-cutaneous-leishmaniasis-a-systematic-review
#8
REVIEW
Nayara Castelano Brito, Ana Rabello, Gláucia Fernandes Cota
BACKGROUND: The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent antimony (Sbv) compounds administered parenterally, despite their recognized toxicity, which requires frequent laboratory monitoring and complicates their use in areas with scarce infrastructure. As result of these drawbacks, the WHO Expert Committee on leishmaniasis has expanded the recommendations for the use of local therapies, including Sbv intralesional infiltration (IL-Sbv), as CL therapy alternatives even in the New World...
2017: PloS One
https://www.readbyqxmd.com/read/28776770/cutaneous-leishmaniasis-by-leishmania-infantum-behind-granulomatous-lesions-of-unknown-aetiology
#9
G Merino-Espinosa, V Corpas-López, V Díaz-Sáez, F Morillas-Márquez, J Tercedor-Sánchez, J M Azaña-Defez, J López-Hidalgo, J Aneiros-Fernández, J Martín-Sánchez
BACKGROUND: Cutaneous leishmaniasis (CL) is underestimated in Spain as in other European countries due to the polymorphism of its clinical manifestations and histopathological features discouraging doctors from suspecting leishmaniasis. Mucosal manifestations (ML) are misdiagnosed due to the fact that they often mimic cancer. OBJECTIVES: Given that leishmaniasis may be masked as different granulomatous diseases in Leishmania infantum endemic areas, the aim of this study was to verify this misdiagnosing and contributes to the improvement of CL/ML diagnosis...
August 3, 2017: Journal of the European Academy of Dermatology and Venereology: JEADV
https://www.readbyqxmd.com/read/28722607/mucosal-leishmaniasis-a-retrospective-study-of-327-cases-from-an-endemic-area-of-leishmania-viannia-braziliensis
#10
Carolina Cincurá, Clara Mônica F de Lima, Paulo R L Machado, Jamary Oliveira-Filho, Marshall J Glesby, Marcus M Lessa, Edgar M Carvalho
Mucosal leishmaniasis (ML) is observed only in about 3% of patients with American tegumentary leishmaniasis (ATL) but has a high potential for destructive, disfiguring, and disabling sequelae. Prior reports of clinical and epidemiologic features of ML are limited by small numbers of cases. In this study, we evaluated changes in the demographic features and clinical presentation of ML in an endemic area of Leishmania braziliensis transmission over a period of 20 years. The charts of 327 patients with ML diagnosed between 1995 and 2014 were reviewed...
September 2017: American Journal of Tropical Medicine and Hygiene
https://www.readbyqxmd.com/read/28704369/clinical-and-parasitological-factors-in-parasite-persistence-after-treatment-and-clinical-cure-of-cutaneous-leishmaniasis
#11
Alvaro J Martínez-Valencia, Carlos Frisherald Daza-Rivera, Mariana Rosales-Chilama, Alexandra Cossio, Elkin J Casadiego Rincón, Mayur M Desai, Nancy Gore Saravia, María Adelaida Gómez
BACKGROUND: The determinants of parasite persistence or elimination after treatment and clinical resolution of cutaneous leishmaniasis (CL) are unknown. We investigated clinical and parasitological parameters associated with the presence and viability of Leishmania after treatment and resolution of CL caused by L. Viannia. METHODS: Seventy patients who were treated with meglumine antimoniate (n = 38) or miltefosine (n = 32) and cured, were included in this study...
July 2017: PLoS Neglected Tropical Diseases
https://www.readbyqxmd.com/read/28687071/recurrence-of-visceral-and-muco-cutaneous-leishmaniasis-in-a-patient-under-immunosuppressive-therapy
#12
Gilles Darcis, Gert Van der Auwera, Jean-Baptiste Giot, Marie-Pierre Hayette, Françoise Tassin, Jorge Arrese Estrada, Lieselotte Cnops, Michel Moutschen, Laurence de Leval, Philippe Leonard
BACKGROUND: Leishmaniasis is a protozoan disease caused by parasites of the genus Leishmania, transmitted to humans by sandflies. The diagnosis of leishmaniasis is often challenging as it mimics many other infectious or malignant diseases. The disease can present in three ways: cutaneous, mucocutaneous, or visceral leishmaniasis, which rarely occur together or consecutively. CASE PRESENTATION: The patient was a 52 years old immunosuppressed Belgian woman with a long history of severe rheumatoid arthritis...
July 7, 2017: BMC Infectious Diseases
https://www.readbyqxmd.com/read/28686398/-leishmaniasis-an-infection-of-travellers-and-migrants
#13
Lena Jessen, Benoît Bard, Xavier Grenon, Frank Bally
Leishmaniasis is an infection of the tropical to temperate zone, occasionally imported in our regions by travellers and migrants. Leishmania parasites are transmitted by the sting of a sand fly, Phlebotomus or Lutzomyia, and causes two clinical syndromes with either cutaneous, also mucosal, or disseminated involvement. Clinical suspicion needs a confirmation by the detection of the parasite. The treatment is adapted to the patient, the clinical presentation, the region, the species and the availability. Cutaneous leishmaniasis can be observed only or treated by topical or systemic regimens...
October 12, 2016: Revue Médicale Suisse
https://www.readbyqxmd.com/read/28602279/an-elisa-immunoassay-employing-a-conserved-leishmania-hypothetical-protein-for-the-serodiagnosis-of-visceral-and-tegumentary-leishmaniasis-in-dogs-and-humans
#14
COMPARATIVE STUDY
Ana Maria R S Carvalho, Lourena E Costa, Beatriz C S Salles, Thaís T O Santos, Fernanda F Ramos, Mariana P Lima, Miguel A Chávez-Fumagalli, Bruna T Silvestre, Áquila S B Portela, Bruno M Roatt, Julia A G Silveira, Denise U Gonçalves, Danielle F Magalhães-Soares, Mariana C Duarte, Daniel Menezes-Souza, Eduardo A F Coelho
In the present study, a conserved Leishmania hypothetical protein, namely LiHypA, was evaluated for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans. This protein showed a high amino acid sequence homology between viscerotropic and cutaneotropic Leishmania species. An enzyme-linked immunosorbent assay (ELISA) was developed using the recombinant antigen (rLiHypA), in addition to the A2 protein and two parasite antigenic preparations, which were used as controls. Regarding human diagnosis, results showed that rLiHypA was more sensitive and specific than ELISA-L...
August 2017: Cellular Immunology
https://www.readbyqxmd.com/read/28500815/oral-pentoxifylline-associated-with-pentavalent-antimony-a-randomized-trial-for-cutaneous-leishmaniasis
#15
RANDOMIZED CONTROLLED TRIAL
Graça Brito, Mayra Dourado, Luiz Henrique Guimarães, Everson Meireles, Albert Schriefer, Edgar Marcelino de Carvalho, Paulo Roberto Lima Machado
AbstractCutaneous leishmaniasis (CL) by Leishmania braziliensis is associated with decreasing cure rates in Brazil. Standard treatment with pentavalent antimony (Sb(v)) cures only 50-60% of the cases. The immunopathogenesis of CL ulcer is associated with high interferon-γ and tumor necrosis factor (TNF) production. Pentoxifylline, a TNF inhibitor, has been successfully used in association with Sb(v) in mucosal and cutaneous leishmaniasis. This randomized, double-blind, and placebo-controlled trial aimed to evaluate the efficacy and safety of oral pentoxifylline plus Sb(v) versus placebo plus Sb(v) in patients with CL in Bahia, Brazil...
May 2017: American Journal of Tropical Medicine and Hygiene
https://www.readbyqxmd.com/read/28397969/aim2-inflammasome-is-associated-with-disease-severity-in-tegumentary-leishmaniasis-caused-by-leishmania-v-braziliensis
#16
R B Moreira, C Pirmez, M P de Oliveira-Neto, L S Aguiar, A J S Gonçalves, L O R Pereira, L Abreu, M P De Oliveira
The inflammasome is a multiprotein signalling platform involved in the pathogenesis of various inflammatory skin diseases. Herein, we investigated gene and protein expression of the inflammasome molecules AIM2 and NLRP3 in active lesions from patients with L. (V.) braziliensis-associated tegumentary leishmaniasis (TL) and correlated these findings with the clinical presentations and responses to therapy. Real-time PCR assays showed a significantly higher AIM2 gene expression in mucosal leishmaniasis (ML) compared with that in cutaneous leishmaniasis (CL)...
April 11, 2017: Parasite Immunology
https://www.readbyqxmd.com/read/28289158/annexin-a1-is-involved-in-the-resolution-of-inflammatory-responses-during-leishmania-braziliensis-infection
#17
Leandro G Oliveira, Míriam C Souza-Testasicca, Juliana P Vago, Amanda Braga Figueiredo, Adriana M C Canavaci, Luiza Oliveira Perucci, Tatiana P Teixeira Ferreira, Eduardo A F Coelho, Denise Utsch Gonçalves, Manoel Otávio C Rocha, Patrícia M R E Silva, Cláudia N Ferreira, Celso Queiroz-Junior, Lirlândia P Sousa, Ana Paula Fernandes
Leishmaniases are diseases caused by several Leishmania species. Leishmania (Viannia) braziliensis can cause localized cutaneous leishmaniasis (LCL), which heals spontaneously, or mucosal leishmaniasis (ML), characterized by chronic and intense inflammation and scanty parasitism. Annexin A1 (AnxA1) is a protein involved in modulation and resolution of inflammation through multiple mechanisms. In the present study, the role of AnxA1 was investigated in L. braziliensis-infected BALB/c mice. AnxA1 levels increased at the peak of tissue lesion and parasitism in infected mice...
April 15, 2017: Journal of Immunology: Official Journal of the American Association of Immunologists
https://www.readbyqxmd.com/read/28239875/american-cutaneous-leishmaniasis-in-situ-immune-response-of-patients-with-recent-and-late-lesions
#18
A H S Gomes, R B Martines, C T Kanamura, M L P Barbo, S D Iglezias, J A Lauletta Lindoso, V L Pereira-Chioccola
TNF-α, IFN-γ, IL-10, IL-17, CD68 and CD57 were evaluated in biopsies of patients with American cutaneous leishmaniasis living in Sorocaba, Brazil. The analyses were performed considering the time of lesions from 23 patients with recent lesions (Group I) and 19 patients with late lesions (Group II). All patients were infected with Leishmania (Viannia) braziliensis. Immunostaining cells for CD68, CD57, TNF- α, IFN-γ, IL-10 and IL-17 were performed by immunohistochemistry. Except for CD68 and IL-17, the distribution of in situ for CD57, IL-10, TNF-α and IFN-γ showed that patients with recent lesions expressed higher levels than those with late lesions...
April 2017: Parasite Immunology
https://www.readbyqxmd.com/read/28150041/evaluation-of-a-hypothetical-protein-for-serodiagnosis-and-as-a-potential-marker-for-post-treatment-serological-evaluation-of-tegumentary-leishmaniasis-patients
#19
Mariana Pedrosa Lima, Lourena Emanuele Costa, Mariana Costa Duarte, Daniel Menezes-Souza, Beatriz Cristina Silveira Salles, Thaís Teodoro de Oliveira Santos, Fernanda Fonseca Ramos, Miguel Angel Chávez-Fumagalli, Amanda Christine Silva Kursancew, Roberta Passamani Ambrósio, Bruno Mendes Roatt, Ricardo Andrez Machado-de-Ávila, Denise Utsch Gonçalves, Eduardo Antonio Ferraz Coelho
The serodiagnosis for tegumentary leishmaniasis (TL) presents problems related to the sensitivity and/or specificity of the tests. In the present study, an enzyme-linked immunosorbent assay (ELISA) technique was used to evaluate the performance from a Leishmania braziliensis hypothetical protein, LbHyM, in an attempt to compare its serological reactivity with a soluble Leishmania antigenic preparation (SLA) for the serodiagnosis of cutaneous (CL) and mucosal (ML) leishmaniasis. LbHyM was predicted to be a kinesin-like protein by bioinformatics tools...
April 2017: Parasitology Research
https://www.readbyqxmd.com/read/28141598/leishmaniasis-recidivans-in-ethiopia-cutaneous-and-mucocutaneous-features
#20
Federica Dassoni, Frehiwot Daba, Bernard Naafs, Aldo Morrone
Cutaneous leishmaniasis (CL) is endemic in Ethiopia. An unusual clinical form of this disease is leishmaniasis recidivans (LR), a prolonged, relapsing form of cutaneous leishmaniasis resembling tuberculosis of the skin that may persist for many years with a chronic and relapsing course. This rare variant has been shown to be caused by Leishmania tropica species in the Old World and by Leishmania braziliensis, Leishmania amazonensis, Leishmania panamensis, and Leishmania guyanensis in the New World, as reported in various studies...
January 30, 2017: Journal of Infection in Developing Countries
keyword
keyword
50609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"